All relevant evidence will be considered, analysed and used as appropriate including during hearings, when preparing findings, preparing interim reports and when preparing the final report and recommendations.
Some readers may find parts of the evidence upsetting or distressing.
Evidences list
(Linda) AAS Witness Statement
This document is the witness statement provided by anonymous witness (Linda) AAS to the Inquiry. The evidence was read in at an Inquiry Hearing on 6 December 2017, and was heard at an Inquiry Hearing on 8 June 2022.
(Mike) FEP Witness Statement
This document is the witness statement provided by anonymous witness (Mike) FEP to the Inquiry. This evidence was heard at an Inquiry Hearing on 8 June 2022.
Veronica Altham Witness Statement
This document is the witness statement provided by witness Veronica Altham to the Inquiry. This evidence was heard at an Inquiry hearing on 29 November 2018, and read in at an Inquiry Hearing on 8 June 2022.
(John) EEV Witness Statement
This document is the witness statement provided by anonymous witness (John) EEV to the Inquiry. This evidence was read in at an Inquiry Hearing on 8 June 2022.
(Ruby) EET Witness Statement
This document is the witness statement provided by anonymous witness (Ruby) EET to the Inquiry. This evidence was heard at an Inquiry Hearing on 8 June 2022.
(Alison) AAW Witness Statement
This document is the witness statement provided by anonymous witness (Alison) AAW to the Inquiry. This evidence was read in at an Inquiry hearing on both 6 December 2017 and 8 June 2022.
(Isobel) EEH Witness Statement
This document is the witness statement provided by anonymous witness (Isobel) EEH to the Inquiry. The evidence was read in at an Inquiry Hearing on 7 June 2022.
(Tam) FDB Witness Statement
This document is the witness statement provided by anonymous witness (Tam) FDB to the Inquiry. The evidence was heard at an Inquiry Hearing on 7 June 2022.
(Lauren) FDA Witness Statement
This document is the witness statement provided by anonymous witness (Lauren) FDA to the Inquiry. The evidence was heard at an Inquiry Hearing on 7 June 2022.